Acadia Pharmaceuticals Inc. (ACAD)

Acadia Pharmaceuticals (ACAD) sees a surge in social media buzz and positive sentiment, driven by strong trial results for trofinetide and recent analyst upgrades. The stock is trading near a 52-week high, indicating significant investor interest.

About Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc. is a healthcare company focused on treatments for neurological and related disorders.
Acadia Pharmaceuticals Inc. uses the ticker $ACAD for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Acadia Pharmaceuticals Inc. (ACAD) social dominance is up 268% from the previous week.
Acadia Pharmaceuticals Inc. (ACAD) sentiment is up 100% from the previous week.
Acadia Pharmaceuticals Inc. (ACAD) creators is up 169.44% from the previous week.
Acadia Pharmaceuticals Inc. (ACAD) engagements is up 64.03% from the previous week.
Acadia Pharmaceuticals Inc. (ACAD) mentions is up 123.19% from the previous week.
Acadia Pharmaceuticals Inc. (ACAD) posts created is up 117.65% from the previous week.

Price: $22

Price 24-Hour Time-Series Raw Data
The stock is trading near a 52-week high, supported by positive trial results for trofinetide and recent analyst upgrades. The surge in social media activity and positive sentiment likely contributes to this upward trend, despite some short-term price volatility.

24-Hour: 0.64% 7-Day: -5.12% 30-Day: -15.24%

1-Year High: $28.10 on 2025-12-22
1-Year Low: $14.10 on 2025-04-08

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Acadia Pharmaceuticals Inc. (ACAD) is currently AltRank #1,349 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] [----]
[--] Month: [-----] +422
[--] Months: [-----] +973
[--] Year: [-----] +919
1-Year High: [-----] on 2026-01-29
1-Year Low: [--] on 2025-12-20

Galaxy Score: [--]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-05-16
1-Year Low: [--] on 2025-06-01

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] +64%
[--] Month: [------] -38%
[--] Months: [---------] -32%
[--] Year: [---------] +7.70%
1-Year High: [-------] on 2025-09-24
1-Year Low: [---] on 2025-05-03

Engagements by network (24h): TikTok: [--] Reddit: [--] X: [-----] YouTube: [---]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +123%
[--] Month: [---] +10%
[--] Months: [-----] -33%
[--] Year: [-----] +62%
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2026-01-25

Mentions by network (24h): TikTok: [--] Reddit: [--] X: [--] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Acadia Pharmaceuticals Inc. (ACAD) in the last [--] hours which is down 56% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +169%
[--] Month: [---] +5.70%
[--] Months: [---] -49%
[--] Year: [-----] +105%
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-05-03

The most influential creators that mention Acadia Pharmaceuticals Inc. in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@Hamnakedshorts	[--]	[-----]	[--]	[-----]
@BuyTheUgly	[--]	[--]	[--]	[---]
@stocket_rocket	[--]	[--]	[--]	[--]
@mariostario2019	[--]	[--]	[--]	[--]

Sentiment: 50%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 50%
Daily Average: 72%
[--] Week: 100% +50%
[--] Month: 44% -36%
[--] Months: 44% -44%
[--] Year: 44% -23%
1-Year High: 100% on 2025-04-23
1-Year Low: 23% on 2025-12-11

Most Supportive Themes:

Positive Trial Results: (45%) Acadia Pharmaceuticals announced positive Phase [--] trial results for trofinetide in Rett syndrome.
Analyst Upgrades and Strong Earnings: (30%) Strong earnings and analyst upgrades have driven ACAD to a 52-week high.

Most Critical Themes:

Price Volatility: (10%) The stock has experienced price fluctuations, with a 24-hour change of -0.15% and varying performance over longer periods.

Social Dominance: 0.00262%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00262%
Daily Average: 0.013%
[--] Week: 0.0092% +0.0067%
[--] Month: 0.0085% +0.0039%
[--] Months: 0.0085% -0.004%
[--] Year: 0.0085% -0.01%
1-Year High: 0.044% on 2025-06-29
1-Year Low: 0.002% on 2026-01-25

Market Dominance: 0.00422%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00422%
Daily Average: 0%
1-Year High: 0.184% on 2026-02-06
1-Year Low: 0.00422% on 2026-02-16

Market Cap: $3,727,075,429

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $3,727,075,429
Daily Average: $3,712,699,724
[--] Week: $3,727,075,429 -5.10%
[--] Month: $3,727,075,429 -15%
[--] Months: $3,727,075,429 -11%
[--] Year: $3,727,075,429 +12%
1-Year High: $4,747,241,785 on 2025-12-22
1-Year Low: $2,351,718,090 on 2025-04-08

Top Acadia Pharmaceuticals Inc. Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"Head of SEC Mr Pitt telling us how to stop and fix naked shorting fraud Mr Harvey Pitt on how to stop Naked shorting $NRGV $FNGR $PLTR $SNOW $HLP $AMZN $GOOGL $AMZN $NWBO $NNNN $MU $ORCL $DELL $TSLA $EKSO $PLUG $FCEL $EXAS $ROOT $UH $BA $NVDA $VERI $CYDY $MTEN $DVAX $TXP $AGEN $VUZI $MDXG $PRTA $APPS $ACAD $CRBP $DOLE https://t.co/bawqxVX7Qk Mr Harvey Pitt on how to stop Naked shorting $NRGV $FNGR $PLTR $SNOW $HLP $AMZN $GOOGL $AMZN $NWBO $NNNN $MU $ORCL $DELL $TSLA $EKSO $PLUG $FCEL $EXAS $ROOT $UH $BA $NVDA $VERI $CYDY $MTEN $DVAX $TXP $AGEN $VUZI $MDXG $PRTA $APPS $ACAD $CRBP $DOLE"
X Link @Hamnakedshorts 2026-02-16T10:24Z [----] followers, [---] engagements

"Mr Harvey Pitt on how to stop Naked shorting $NRGV $FNGR $PLTR $SNOW $HLP $AMZN $GOOGL $AMZN $NWBO $NNNN $MU $ORCL $DELL $TSLA $EKSO $PLUG $FCEL $EXAS $ROOT $UH $BA $NVDA $VERI $CYDY $MTEN $DVAX $TXP $AGEN $VUZI $MDXG $PRTA $APPS $ACAD $CRBP $DOLE https://www.youtube.com/watchv=A7eiESsSDtE https://www.youtube.com/watchv=A7eiESsSDtE"
X Link @Hamnakedshorts 2026-02-15T20:57Z [----] followers, [----] engagements

"Biotech Stock Catalyst Watchlist for Q1 [----] Probability of approval score card is below $ETON PDUFA $OCUL Phase [--] $TARA Phase [--] $REGN BLA $ASND PDUFA $XOMA Phase [--] $GOSS Phase [--] $CAPR BLA $RLAY Phase 1/2 $RYTM PDUFA $TELO Pre-clinical $RCKT PDUFA $LNTH PDUFA $ABVX Phase [--] $ALMS Phase [--] $MGX Preclinical $CTNM Phase 1b $SXTP Phase [--] $NAYA Phase 1/2a $ACAD Phase [--] https://twitter.com/i/web/status/2022341817685975187 https://twitter.com/i/web/status/2022341817685975187"
X Link @Biopharma_Watch 2026-02-13T16:07Z [----] followers, [----] engagements

"Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK TGFb $ALNY RNAi $RVMD RASmuti $BBIO $CRNX $CPRX $ABEO $KYMR $NUVL $IMCR $ACAD $CORT $NBIX Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK"
X Link @Andre_AGTC 2025-09-30T14:34Z [----] followers, 36.6K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing